Search

Your search keyword '"Duan, T."' showing total 1,017 results

Search Constraints

Start Over You searched for: Author "Duan, T." Remove constraint Author: "Duan, T."
1,017 results on '"Duan, T."'

Search Results

2. ULK1 Depletion Protects Mice from Diethylnitrosamine-Induced Hepatocarcinogenesis by Promoting Apoptosis and Inhibiting Autophagy

3. Unveiling the superconducting mechanism of Ba$_{0.51}$K$_{0.49}$BiO$_3$

4. Benefits of Endovascular Treatment in Late Window for Acute Ischemic Stroke Selected without CT Perfusion: A Real-World Study

5. Association between adenomyosis volume and adverse perinatal outcomes: multicenter cohort study.

7. The application of 4S atrial fibrillation scheme in predicting atrial arrhythmia recurrence after catheter ablation

11. A safety culture assessment by mixed methods at a public maternity and infant hospital in China

20. Feasibility and Safety of Neoadjuvant Alectinib in Pulmonary Invasive Mucinous Adenocarcinoma with ALK Rearrangement: Case Report and Literature Review

21. A modified lower-order theory for FG beam with circular cross-section

22. 548P Progression-free survival (PFS) and overall survival (OS) in advanced/recurrent (AR) mismatch repair deficient/microsatellite instability–high or proficient/stable (dMMR/MSI-H or MMRp/MSS) endometrial cancer (EC) treated with dostarlimab in the GARNET study

23. 549P Progression-free survival (PFS) and overall survival (OS) in patients (pts) with mismatch repair deficient (dMMR) solid tumors treated with dostarlimab in the GARNET study

25. A Case of Pulmonary Embolism with Sarcomatoid Malignant Pleural Mesothelioma with Long-Term Pleural Effusion

26. Synthesis, X-ray characterization and theoretical study of all-cis 1,4:2,3:5,8:6,7-tetraepoxynaphthalenes: on the importance of the through-space α-effect

30. Safety and Efficacy of Dostarlimab in Patients With Recurrent/Advanced Non-small Cell Lung Cancer: Results from Cohort E of the Phase I GARNET Trial

32. WHO Statement on Caesarean Section Rates

33. Second-trimester abdominal circumference discordance and adverse perinatal outcomes in monochorionic twins.

34. O003/#149 Antitumor activity of dostarlimab in patients with advanced or recurrent mismatch repair–deficient or proficient–cancer by prior therapy: results from the garnet study

35. What is an appropriate caesarean delivery rate for China: a multicentre survey

36. 272 Dostarlimab in advanced/recurrent mismatch repair deficient/microsatellite instability high or proficient/stable endometrial cancer: the GARNET study

37. 820TiP ENGOT-EN6/GOG-3031/NSGO-CTU-RUBY part 2: A phase III, randomized, double-blind, study of dostarlimab + carboplatin-paclitaxel followed by dostarlimab + niraparib versus placebo (PBO) + carboplatin-paclitaxel followed by PBO in recurrent or advanced endometrial cancer (EC)

38. 76P Analysis of antitumor activity of dostarlimab by tumor mutational burden (TMB) in patients (pts) with endometrial cancer (EC) in the GARNET trial

42. A nomogram integrating ferroptosisand immune-related biomarker for prediction of prognosis and diagnosis in kidney renal clear cell carcinoma.

45. Influence of a Wavy Blade-End Applied in an Axial Compressor Cascade on the Secondary Flow of the Passage.

Catalog

Books, media, physical & digital resources